Biomarkers and Precision Medicine meeting

Terrace Room, RCPath; 10 September 2026, 13:30 – 17:00 BST

Chair: Professor Peter Johnston, RCPath Vice President for Workforce and Corporate Engagement

Time	Session
13:30	Arrival and registration – refreshments available
14:00	Welcome from Professor Peter Johnston, RCPath VP for Workforce and Corporate Engagement Keynote address – Immunohistochemistry in the Genomic Era, Professor Manuel Salto-Tellez, Institute of Cancer Research Session organised by MSD-UK
14:45	Translating research into patient care Confirmed speakers: Dr Shirley Hopper, Expert Medical Assessor, Biological Products, MHRA Professor Tim Kendall, Chair of Pathological Society Clinical Trials Pathology Subcommittee Professor Louise Jones, Professor of breast pathology, Queen Mary University of London and Genomics England
15:30	Coffee break
16:00	Panel discussion on opportunities and barriers in treatment-guiding biomarkers in UK cancer services Introduction and context setting from Dr Bernie Croal, RCPath President Panel discussion chaired by Professor Peter Johnston Confirmed panellists: Professor Peter Johnson, National Clinical Director for Cancer, NHSE Professor Naomi Allen, Chief Scientist, UK Biobank Professor Mike Hubank, Scientific Director, The Royal Marsden and Reader in Translational Genomics, ICR Helen Dent, CEO, BIVDA Other panellists have been invited from NICE and MHRA
17:00	Close

Disclaimer: MSD provided sponsorship to support costs of this event, without influencing the agenda or arrangements (other than MSD-specific keynote session).

Please note: Panellists for the final session are subject to change.